Elena Yu. Nosova, Anastasia A. Bukatina, Yulia D. Isaeva, Marina V. Makarova, Ksenia Yu. Galkina and Arkadyi M. Moroz INTRODUCTION
|
|
- Logan Hubbard
- 6 years ago
- Views:
Transcription
1 Journal of Medical Microbiology (2013), 62, DOI /jmm Analysis of mutations in the gyra and gyrb genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin Elena Yu. Nosova, Anastasia A. Bukatina, Yulia D. Isaeva, Marina V. Makarova, Ksenia Yu. Galkina and Arkadyi M. Moroz Correspondence Elena Yu. Nosova Received 3 May 2012 Accepted 24 September 2012 Moscow Scientific and Clinical Antituberculosis Center, Moscow Government Health Department, Stromynka 10, Moscow , Russia The purpose of the present study was to analyse mutations in the gyra and gyrb genes of Mycobacterium tuberculosis and define the possible correlation between these mutations and resistance to levofloxacin (LVX), moxifloxacin (MFX) and gatifloxacin (GAT), based on their MICs. One hundred and forty-two M. tuberculosis clinical isolates were collected from pulmonary tuberculosis patients in the Moscow region. All M. tuberculosis strains were tested for drug susceptibility to rifampicin and isoniazid using the BACTEC MGIT 960 System and to ofloxacin (OFX) using the absolute concentration method on solid Lowenstein Jensen slants. All in all, 68 strains were selected at random (38 strains were resistant and 30 were susceptible to OFX) for further analysis using the TB-BIOCHIP-2 test system and DNA sequence analysis. The MICs of LVX, MFX and GAT for selected strains were determined using the BACTEC MGIT 960 System. Mutations in the gyra gene were observed in 36 out of 38 (94.7 %) OFX-resistant M. tuberculosis strains. Asn538Asp and Asp500His substitutions in the gyrb gene only were found in two (5.3 %) strains. Twenty-nine out of 30 OFX-sensitive M. tuberculosis strains had no mutations in either gene. One (3.3 %) OFX-sensitive M. tuberculosis strain carried an Arg485His substitution in gyrb. The results of our investigation showed that there is no clear correlation between the type of mutation in the genes gyra and gyrb, and the MIC levels of LVX, MFX and GAT for resistant strains. Mutations in gyra and Asn538Asp, and Asp500His substitutions in gyrb were associated with cross-resistance of M. tuberculosis to fluoroquinolones. The substitution Arg485His in gyrb does not confer resistance to LVX, MFX and GAT in M. tuberculosis. INTRODUCTION Fluoroquinolones (FQs) are highly active antimicrobial agents, which are widely used in chemotherapy against multidrug-resistant (MDR) tuberculosis (TB). However, the application of ofloxacin (OFX), ciprofloxacin and levofloxacin (LVX) for the treatment of undiagnosed respiratory infections led to the development of resistance in Mycobacterium tuberculosis isolates (Wang et al., 2007). Moreover, the initial occurrences of resistance to FQs were observed in MDR strains and isoniazid (IHN)- and rifampicin (RIF)-susceptible strains isolated from newly diagnosed TB patients (Delgado & Telenti, 1996; Xu et al., 2009). Abbreviations: FQ, fluoroquinolone; GAT, gatifloxacin; IHN, isoniazid; LVX, levofloxacin; MDR, multidrug resistant; MFX, moxifloxacin; OFX, ofloxacin; RIF, rifampicin; SNP, single nucleotide polymorphism; TB, tuberculosis. The most promising drugs undergoing phase III trials are the fourth generation FQs, such as moxifloxacin (MFX) and gatifloxacin (GAT), which demonstrated high in vivo and in vitro activities against MDR strains and OFX-resistant and ciprofloxacin-resistant MDR strains (Zhao et al., 1999; Rodríguez et al., 2002; Poissy et al., 2010; Merle et al., 2012). Recent studies have shown that resistance to all FQs is due to mutations (single nucleotide polymorphisms, SNPs) not only in the gyra (320 bp) gene, but also in the gyrb (375 bp) gene, which encode the respective subunits of the DNA topoisomerase gyrase (Takiff et al., 1994; Ginsburg et al., 2003; Shi et al., 2006; Lau et al., 2011). The most common mutations in the gyra gene are Ala90Val, Asp94 (Gly, Ala, His, Asn or Tyr) and Ser91Pro, the Gly88Cys mutation is found less frequently (Shi et al., 2006; Wang et al., 2007; van Doorn et al., 2008; Feuerriegel et al., 2009). An SNP in one of these four positions leads to FQ resistance in M. tuberculosis in vitro, including resistance to G 2013 SGM Printed in Great Britain
2 M. tuberculosis genes gyra and gyrb: resistance to FQs MFX and GAT (Kam et al., 2006; Von Groll et al., 2009). About 7 % of strains carry mutations in the gyrb gene (Wang et al., 2007). At present, Arg485 (His, Cys), Ser486Phe, Asp495Asn, Asn533Thr, Asn538 (Thr, Asp), Thr539Pro, Asp500 (Ala, His, Asn), Gly509Ala, Glu540 (Val, Asp) nucleotide substitutions have been described in the quinolone-resistance-determining region of the gyrb gene (Pitaksajjakul et al., 2005; Feuerriegel et al., 2009; An et al., 2009). These SNPs occur independently in gyrb,orin combination with mutations in gyra (Von Groll et al., 2009). High MIC values for FQ-resistant strains are associated with the appearance of at least two mutations in gyra, the substitutions Asp500 (Asn, His) and Glu540 (Val, Asp) in gyrb or mutations in both genes (An et al., 2009; Von Groll et al., 2009; Cui et al., 2011). The purpose of our study was to analyse mutations in the gyra and gyrb genes and define the possible correlation between these mutations and resistance to LVX, MFX and GAT, based on the determination of MICs in the liquid medium Middlebrook 7H9 using the automated BACTEC MGIT 960 System. METHODS Bacterial strains. A total of 142 M. tuberculosis clinical isolates were collected from pulmonary TB patients in the Moscow region. Identification of the M. tuberculosis strains was performed by using molecular (identification of insertion sequence IS6110) and microbiological (growth rate, pigmentation, colony morphology, microscopy of Ziehl Neelsen-stained smears) methods, and biochemical tests (niacin and catalase production, nitrate reduction, sodium salicylate susceptibility) (Order of the Ministry of Health of the Russian Federation, 2003; Siddiqi & Rusch-Gerdes, 2007; Gryadunov et al., 2011). All M. tuberculosis strains were tested for drug susceptibility to IHN and RIF using the BACTEC MGIT 960 System and for susceptiblity to OFX using the absolute concentration method on solid Lowenstein Jensen (L J) slants. A total of 68 strains were selected at random (38 strains were resistant and 30 were susceptible to OFX) for further analysis. Drug susceptibility testing (DST). First-line DST for IHN and RIF was performed using the BACTEC 960 System, according to the manufacturer s instructions (Siddiqi & Rusch-Gerdes, 2007). DST for OFX was performed using the absolute concentration method on L J slants with the breakpoint concentration 2 mg l 21, as recommended by the Russian Ministry of Health (Order of the Ministry of Health of the Russian Federation, 2003). MIC determination. LVX (28266; Sigma-Aldrich), MFX (SRP06644m; Sequoia Research Products) and GAT (SRP01230g; Sequoia Research Products) stock solutions were prepared at 1 mg ml 21 in deionized water, filter-sterilized and were stored at 20 uc. Final concentrations of LVX ranged from to 32.0 mg l 21, MFX from to 10.0 mg l 21 and GAT from to 6.0 mg l 21. Test procedures for the determination of the MICs of LVX, MFX and GAT were those as described by Rüsch-Gerdes et al. (2006) on second-line DST. The strain H37Rv (ATCC 25618) was used as a control. Resistance was defined as an MIC of 2 mgl 21 for LVX, 0.5 mg l 21 for MFX and GAT. DNA extraction. An analysis using the TB-BIOCHIP-2 test system for the identification of mutations in gyra, including DNA extraction, PCR, electrophoresis and hybridization on biochips, was performed as described in the manufacturer s manual, based on original publications (Antonova et al., 2008; Gryadunov et al., 2011). The TB-BIOCHIP-2 test permits the detection of nine types of mutations in five polymorphic codons (88, 90, 91, 94, 95) of the quinoloneresistance-determining region of the gyra gene. Codon 95 contains a natural polymorphism, Ser (AGC) to Thr (ACC), which does not lead to FQ resistance in M. tuberculosis. Sequencing. DNA sequencing of the gyra and gyrb genes was performed after the DNA was amplified by PCR in the automated sequencer GS Junior (Roche) using the primers gyraf (59-CTATGC- AATGTTCGATTCCGGCTTC-39) andgyrar (59-ACTGTCTCCTCG- TCGATTTCCCT-39) for the gyra gene and gyrbf(59-agagttggtg- CGGCGTAAGA-39) and gyrbr (59-AACACATGCCCGTTCTCGAT- 39) for the gyrb gene. RESULTS We analysed 68 M. tuberculosis strains. Thirty-eight strains were resistant and 30 were susceptible to OFX. Among the 38 OFX-resistant strains, 35 were also resistant to RIF and IHN (MDR strains), two were resistant to RIF and one was susceptible to both drugs. Among the 30 susceptible strains, 22 were also susceptible to RIF and IHN, three were resistant to RIF and IHN, two were resistant to RIF and three were resistant to IHN. Mutations in gyra were observed in 36 out of 38 (94.7 %) OFX-resistant strains. Two (5.3 %) OFX-resistant strains carried mutations in gyrb only (Asn538Asp, Asp500His). Twenty-nine out of 30 OFX-susceptible strains displayed no mutations in gyra/gyrb, apart from a Ser95Thr natural polymorphism in gyra, which was detected in 19 OFXsusceptible and in all OFX-resistant strains. One (3.3 %) susceptible strain carried an Arg485His substitution in gyrb. Substitutions in codons 94 (55.3 %) and 90 (23.7 %) occurred the most frequently. In four out of 36 strains, double substitutions were detected. The spectrum of mutations is shown in Table 1. LVX, MFX and GAT MICs for the 30 OFX-susceptible strains, including strains with the Arg485His substitution in gyrb, ranged from to 1.0 mg l 21, from to 0.25 mg l 21 and from to mg l 21, respectively. LVX, MFX and GAT MICs for the 38 OFX-resistant strains were relatively higher than those obtained for the OFXsusceptible strains (Table 2). The MICs of LVX, MFX and GAT for 14 out of 15 strains with Asp94 mutations (Asp94Gly, Asp94Tyr and Asp94His) were high; however, for strains with the Asp94Ala mutation, they were not. The MIC of LVX for M. tuberculosis strains with the mutation Ala90Val ranged from 2.0 to 8.0 mg l 21 and the MICs of MFX and GAT for these strains ranged from 0.5 to 2.0 mg l 21. LVX, MFX and GAT MICs for strains with double mutations in gyra (Asp94Gly, Ala90Val) were high,.32.0, 8.0 and 4.0 mg l 21, respectively. At the same time, MICs for strains with double substitutions (Gly88Ala and His70Arg, Asp94Tyr and Ala90Val) were lower (2.0 mg l 21 for LVX, 1.0 mg l 21 for MFX and mg l 21 for 109
3 E. Y. Nosova and others Table 1. Mutation spectrum in M. tuberculosis genes gyra and gyrb All M. tuberculosis strains were tested for drug susceptibility to OFX using the absolute concentration method on solid L J slants. Mutation No. of strains (%) GAT). However, a four- to eightfold decrease in the MFX and GAT MIC values was observed when compared with the MIC of LVX. Two OFX-resistant and one OFX-susceptible strains carried mutations only in gyrb. LVX, MFX and GAT MICs for a strain with Asn538Asp SNP were 2.0, 0.5 and 1.0 mg l 21, respectively, and the MICs for a strain with Asp500His SNP were 4.0, 0.5 and 1.0 mg l 21, respectively. An OFX-sensitive strain with the Arg485His substitution in gyrb was sensitive to LVX (MIC51.0 mg l 21 ), MFX (MIC50.25 mg l 21 ) and GAT (MIC50.25 mg l 21 ). DISCUSSION OFX-resistant OFX-susceptible gyra wild-type 10 (33.3) gyra Ser95Thr 38 (100) 19 (63.4) gyra Ala90Val 9 (24) gyra Asp94Gly 13 (34) gyra Asp94Ala 6 (16) gyra Asp94Tyr 1 (2.6) gyra Asp94His 1 (2.6) gyra Ser91Pro 1 (2.6) gyra Gly88Cys 1 (2.6) gyra Gly88Ala, His70Arg 1 (2.6) gyra Asp94Tyr, Ala90Val 1 (2.6) gyra Asp94Gly, Asp94Asn 1 (2.6) gyra Asp94Gly, Ala90Val 1 (2.6) gyrb Arg485His 1 (3.3) gyrb Asn538Asp 1 (2.6) gyrb Asp500His 1 (2.6) Total FQ resistance in M. tuberculosis occurs due to mutations mostly in the gyra gene, rarely in the gyrb gene (Takiff et al., 1994; Pitaksajjakul et al., 2005; Wang et al., 2007; Feuerriegel et al., 2009). On the other hand, Von Groll et al. (2009) showed that the substitution Asn533Thr in gyrb is associated with resistance to low concentrations of MFX and GAT, but is not associated with resistance to OFX. In addition, previous studies have shown that the level of LVX resistance in LFX-resistant strains (Yin & Yu, 2010) and the level of OFX resistance in OFX-resistant strains (Cui et al., 2011) had no clear correlation with the type of mutation present in gyra and gyrb. In this study all mutations in the gyra gene were associated with phenotypic resistance to all four FQs and crossresistance was observed. High-level MICs of LVX (16.0 and 32.0 mg l 21 ) were detected for three (7.9 %) strains. MFX MICs for two (5.3 %) strains were 4.0 and 8.0 mg l 21. GAT MIC for one (2.36 %) strain was 4.0 mg l 21. Asp94 mutations led to high-level MICs of LVX, MFX and GAT for most strains (Kam et al., 2006; Yin & Yu, 2010). Fourteen (36.8 %) strains were resistant to the lowest LVX concentration (2.0 mg ml 21 ). MFX MIC for seven (18.4 %) strains was 0.5 mg l 21. GAT MIC for 15 (39.5 %) strains was also 0.5 mg l 21 (Table 2). Mutations in the gyra gene detected using the TB-BIOCHIP-2 test system and the identification of a double substitution, Gly88Ala and His70Arg, in one strain by sequence analysis, which were described by Matrat et al. (2006), Mokrousov et al. (2008) and Yin & Yu (2010), showed no clear correlation between the levels of resistance in strains resistant to LVX, MFX and GAT, and the type of mutation that coincided with previously reported data (Von Groll et al., 2009; Yin & Yu, 2010; Cui et al., 2011). Reports concerning the occurrence of FQ-resistant strains with mutations in the gyrb gene have been published (Pitaksajjakul et al., 2005; An et al., 2009; Von Groll et al., 2009; Kim et al., 2011); however, some SNPs (Arg485Leu, Gly551Arg and Gly549Asp) have also been found in FQsusceptible isolates (El Sahly et al., 2011; Cui et al., 2011). In this study, two OFX-resistant and one OFX-susceptible strains carried SNPs only in the gyrb gene. The three substitutions Arg485His, Asn538Asp and Asp500His have been described as mutations connected to FQ resistance (Pitaksajjakul et al., 2005; Wang et al., 2007; Feuerriegel et al., 2009; An et al., 2009). According to our data, OFXresistant strains with mutations Asp500His and Asn538Asp in the gyrb gene only were cross-resistant to LVX, MFX and GAT, as were all OFX-resistant strains with SNPs in the gyra gene only (Table 2). An OFX-susceptible strain with the mutation Arg485His in gyrb was also susceptible to LVX (MIC51.0 mg l 21 ), MFX (MIC50.25 mg l 21 ) and GAT (MIC50.25 mg l 21 ) (Pantel et al., 2011). Other SNPs at this codon, Arg485Cys and Arg485Asn, were detected only in OFX-resistant strains from Uzbekistan, Thailand and Vietnam, and were not detected in the OFXsusceptible strains (Pitaksajjakul et al., 2005; Feuerriegel et al., 2009; Cui et al., 2011). The results from a study of mutations in the gyra and gyrb genes of M. tuberculosis strains obtained from patients with pulmonary TB in the Moscow region of Russia coincided with those from studies in other countries around the world. In conclusion, our data showed that mutations in the gyra gene and the two SNPs Asn538Asp and Asp500His in the gyrb gene are associated with cross-resistance to FQs in M. tuberculosis. The mutation Arg485His in the gyrb gene does not confer resistance to OFX, LVX, MFX or GAT. Also, it has been shown that the levels of resistance to three FQs in resistant strains of M. tuberculosis are not associated with the type of mutation present in the gyra and gyrb genes. It is necessary to conduct further research on a large number 110 Journal of Medical Microbiology 62
4 111 Table 2. Mutations in M. tuberculosis genes gyra and gyrb, and the MICs of LVX, MFX and GAT gyra mutation gyrb mutation No. of strains LVX MFX GAT MIC (mg l 1 ) Cut-off MIC for resistance MIC (mg l 1 ) Cut-off MIC for resistance MIC (mg l 1 ) Cut-off MIC for resistance Ala90Val Asp94Ala Asp94Gly Asp94Tyr Asp94His Ser91Pro Gly88Cys Gly88Ala His70Arg Asp94Tyr Ala90Val Asp94Gly Ala90Val Asp94Gly Asp94Asn Arg485His 1,2.0 1,0.5 1,0.5 Asn538Asp Asp500His M. tuberculosis genes gyra and gyrb: resistance to FQs
5 E. Y. Nosova and others of M. tuberculosis strains to study the role of mutations in the gyrb gene in the development of resistance to FQs. ACKNOWLEDGEMENTS We wish to thank the staff of the Centralized Mycobacteriological Laboratory of the Moscow Scientific and Clinical Antituberculosis Center for supplying bacterial isolates and Mr Danila V. Zimenkov from the Engelhardt Institute of Molecular Biology for performing sequence analysis. REFERENCES An, D. D., Hong Duyen, N. T., Lan, N. T. N., Hoa, D. V., Ha, D. T. M., Kiet, V. S., Thu, D. D. A., Van Vinh Chau, N., Dung, N. H. & other authors (2009). Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob Agents Chemother 53, Antonova, O. V., Gryadunov, D. A., Lapa, S. A., Kuz min, A. V., Larionova, E. E., Smirnova, T. G., Nosova, E. Y., Skotnikova, O. I., Chernousova, L. N. & other authors (2008). Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips. Bull Exp Biol Med 145, Cui, Z., Wang, J., Lu, J., Huang, X. & Hu, Z. (2011). Association of mutation patterns in gyra/b genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in BMC Infect Dis 11, 78. Delgado, M. B. & Telenti, A. (1996). Selected PCR Protocols for Emerging Infectious Diseases. Edited by D. H. Persing. Washington, DC: American Society for Microbiology. El Sahly, H. M., Teeter, L. D., Jost, K. C., Jr, Dunbar, D., Lew, J. & Graviss, E. A. (2011). Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas. J Clin Microbiol 49, Feuerriegel, S., Cox, H. S., Zarkua, N., Karimovich, H. A., Braker, K., Rüsch-Gerdes, S. & Niemann, S. (2009). Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother 53, Ginsburg, A. S., Grosset, J. H. & Bishai, W. R. (2003). Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 3, Gryadunov, D., Dementieva, E., Mikhailovich, V., Nasedkina, T., Rubina, A., Savvateeva, E., Fesenko, E., Chudinov, A., Zimenkov, D. & other authors (2011). Gel-based microarrays in clinical diagnostics in Russia. Expert Rev Mol Diagn 11, Kam, K. M., Yip, C. W., Cheung, T. L., Tang, H. S., Leung, O. C. & Chan, M. Y. (2006). Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Microb Drug Resist 12, Kim, H., Nakajima, C., Yokoyama, K., Rahim, Z., Kim, Y. U., Oguri, H. & Suzuki, Y. (2011). Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance. Antimicrob Agents Chemother 55, Lau, R. W., Ho, P. L., Kao, R. Y., Yew, W. W., Lau, T. C., Cheng, V. C., Yuen, K. Y., Tsui, S. K., Chen, X. & Yam, W. C. (2011). Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyra mutation at position 74. Antimicrob Agents Chemother 55, Matrat, S., Veziris, N., Mayer, C., Jarlier, V., Truffot-Pernot, C., Camuset, J., Bouvet, E., Cambau, E. & Aubry, A. (2006). Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones. Antimicrob Agents Chemother 50, Merle, C. S., Sismanidis, C., Bah Sow, O., Gninafon, M., Horton, J., Lapujade, O., Lo, M. B., Mitchinson, D. A., Perronne, C. & other authors (2012). A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the gatifloxacin for TB (OFLOTUB) project. Trials 13, 61. Mokrousov, I., Otten, T., Manicheva, O., Potapova, Y., Vishnevsky, B., Narvskaya, O. & Rastogi, N. (2008). Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother 52, Order of the Ministry of Health of the Russian Federation (2003). Improvement of tuberculosis-controlling measures in the Russian Federation under no. 109 on March , In Russian; last accessed 5 April bf0f4ed590545f3b c2669ba8 Pantel, A., Petrella, S., Matrat, S., Brossier, F., Bastian, S., Reitter, D., Jarlier, V., Mayer, C. & Aubry, A. (2011). DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrb mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, Pitaksajjakul, P., Wongwit, W., Punprasit, W., Eampokalap, B., Peacock, S. & Ramasoota, P. (2005). Mutations in the gyra and gyrb genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand. Southeast Asian J Trop Med Public Health 36 (Suppl. 4), Poissy, J., Aubry, A., Fernandez, C., Lott, M. C., Chauffour, A., Jarlier, V., Farinotti, R. & Veziris, N. (2010). Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model. Antimicrob Agents Chemother 54, Rodríguez, J. C., Ruiz, M., López, M. & Royo, G. (2002). In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents 20, Rüsch-Gerdes, S., Pfyffer, G. E., Casal, M., Chadwick, M. & Siddiqi, S. (2006). Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 44, Shi, R., Zhang, J., Li, C., Kazumi, Y. & Sugawara, I. (2006). Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyra mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J Clin Microbiol 44, Siddiqi, S. & Rusch-Gerdes, S. (2007). MGIT Procedure Manual. For BACTEC MGIT 960 TB System (Also applicable for Manual MGIT), Mycobacteria Growth Indicator Tube (MGIT), Culture and Drug Susceptibility Demonstration Projects. org/export/sites/default/resourcecentre/find_documentation/pdfs/mgit_ manual_nov_2007.pdf Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., Jr & Telenti, A. (1994). Cloning and nucleotide sequence of Mycobacterium tuberculosis gyra and gyrb genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 38, van Doorn, H. R., An, D. D., de Jong, M. D., Lan, N. T., Hoa, D. V., Quy, H. T., Chau, N. V., Duy, P. M., Tho, D. Q. & other authors (2008). Fluoroquinolone resistance detection in Mycobacterium tuberculosis 112 Journal of Medical Microbiology 62
6 M. tuberculosis genes gyra and gyrb: resistance to FQs with locked nucleic acid probe real-time PCR. Int J Tuberc Lung Dis 12, Von Groll, A., Martin, A., Jureen, P., Hoffner, S., Vandamme, P., Portaels, F., Palomino, J. C. & da Silva, P. A. (2009). Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyra and gyrb. Antimicrob Agents Chemother 53, Wang, J. Y., Lee, L. N., Lai, H. C., Wang, S. K., Jan, I. S., Yu, C. J., Hsueh, P. R. & Yang, P. C. (2007). Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother 59, Xu, P., Li, X., Zhao, M., Gui, X., DeRiemer, K., Gagneux, S., Mei, J. & Gao, Q. (2009). Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob Agents Chemother 53, Yin, X. & Yu, Z. (2010). Mutation characterization of gyra and gyrb genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect 61, Zhao, B. Y., Pine, R., Domagala, J. & Drlica, K. (1999). Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages. Antimicrob Agents Chemother 43,
HHS Public Access Author manuscript Int J Tuberc Lung Dis. Author manuscript; available in PMC 2016 April 01.
Determination of MICs of Levofloxacin for Mycobacterium tuberculosis with gyra Mutations Priti Kambli a, Kanchan Ajbani a, Chaitali Nikam a, Archana Khillari a, Anjali Shetty a, Zarir Udwadia b, Sophia
More informationAssociation of mutation patterns in gyra/b genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009
RESEARCH ARTICLE Open Access Association of mutation patterns in gyra/b genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009 Zhenling Cui *, Jie Wang, Junmei
More informationMolecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China
Title Author(s) Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China Zhu, C; Zhang, Y; Shen, Y; Siu, GKH; Wu, W; Qian, X; Deng, G; Xu,
More informationRapid Diagnosis and Detection of Drug Resistance in Tuberculosis
Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis YAM Wing-Cheong 任永昌 Department of Microbiology The University of Hong Kong Tuberculosis Re-emerging problem in industrialized countries
More informationOptimising patient care in MDR TB with existing molecular screening tests in high burden countries
Optimising patient care in MDR TB with existing molecular screening tests in high burden countries Camilla Rodrigues MD Consultant Microbiologist Hinduja Hospital,India Outline What is the best empiric
More informationY. Hu, 1,2 L. Xu, 2,3 Y. L. He, 2,3 Y. Pang, 4 N. Lu, 2,3 J. Liu, 1 J. Shen, 1 D. M. Zhu, 1 X. Feng, 1 Y. W. Wang, 5 and C. Yang 2,3. 1.
Hindawi BioMed Research International Volume 2017, Article ID 4563826, 9 pages https://doi.org/10.1155/2017/4563826 Research Article Prevalence and Molecular Characterization of Second-Line Drugs Resistance
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou , China; 4
Int J Clin Exp Pathol 2016;9(1):208-215 www.ijcep.com /ISSN:1936-2625/IJCEP0017885 Original Article Reverse dot blot hybridization for detection of gyra mutation for rapid diagnosis of Mycobacterium tuberculosis
More informationNew frontiers: Innovation and Access
8th Regional TB Symposium Tashkent, Uzbekistan Prof. L.N. Chernousova Central Tuberculosis Research Institute (CTRI) Ministry of Health of the Republic of Uzbekistan 28 February 1 March, 2019 1970 1975
More informationFluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada
MAJOR ARTICLE Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada Lorna Bozeman, 1 William Burman, 3 Beverly Metchock, 2 Lauren Welch, 3 Marc Weiner,
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationRapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array
ORIGINAL ARTICLE BACTERIOLOGY Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array W.-L. Huang 1, Z.-J. Hsu 1, T. C. Chang 2 and R.
More informationDepartment of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
Indian J Med Res 135, May 2012, pp 756-762 Variations in the occurrence of specific rpob mutations in rifampicinresistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in
More informationMicrobiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2
The Incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory,
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationReceived 4 June 2013; Final revision 1 August 2013; Accepted 30 August 2013; first published online 27 September 2013
Epidemiol. Infect. (2014), 142, 1328 1333. Cambridge University Press 2013 doi:10.1017/s0950268813002409 SHORT REPORT Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationEvaluation of the MTBDRsl Test for Detection of Second-Line-Drug Resistance in Mycobacterium tuberculosis
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2010, p. 2934 2939 Vol. 48, No. 8 0095-1137/10/$12.00 doi:10.1128/jcm.00201-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Evaluation
More informationA pseudo-outbreak of pre-xdr TB in Kinshasa: A Collateral Damage of False Fluoroquinolone Resistant Detection by GenoType MTBDRsl
JCM Accepts, published online ahead of print on 28 May 2014 J. Clin. Microbiol. doi:10.1128/jcm.00398-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 A pseudo-outbreak of
More informationRapid Diagnosis of Extensively Drug-Resistant Tuberculosis by Use of a Reverse Line Blot Hybridization Assay
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2546 2551 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.02511-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Rapid Diagnosis
More informationDRUG RESISTANCE IN TUBERCULOSIS
DRUG RESISTANCE IN TUBERCULOSIS INTRODUCTION Up to 50 million people may be infected with drug-resistant resistant TB.* Hot zones of MDR-TB such as Russia, Latvia, Estonia, Argentina and the Dominican
More informationDST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?
DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and
More informationDetection of Multidrug Resistance and Characterization of Mutations in Mycobacterium tuberculosis Isolates in Raichur District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 1543-1549 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.185
More informationIdentification of a Serratia marcescens clinical isolate with multiple. Serratia marcescens, a Gram-negative bacillus that belongs to the family
AAC Accepts, published online ahead of print on 13 August 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.00070-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6
More informationIn-vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and. sulfonamides, France
AAC Accepts, published online ahead of print on 23 September 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01683-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 In-vitro
More informationEvaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis
Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt
More informationTransmission of MDR/XDR Tuberculosis in Shanghai. Qian Gao Shanghai Medical College Fudan University
Transmission of MDR/XDR Tuberculosis in Shanghai Qian Gao Shanghai Medical College Fudan University Drug Resistant TB in China The Highest DR-TB Burden Country New TB cases/year Cases with any DR MDR XDR
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationLaboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust
Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral
More informationon September 22, 2018 by guest
JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.06860-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12
More informationEmpirical Treatment of Community-Acquired Pneumonia and the Development of Fluoroquinolone-Resistant Tuberculosis
MAJOR ARTICLE Empirical Treatment of Community-Acquired Pneumonia and the Development of Fluoroquinolone-Resistant Tuberculosis Richard Long, 1 Huey Chong, 3 Vernon Hoeppner, 5 Hareishun Shanmuganathan,
More informationClarithromycin significantly increases linezolid serum concentrations
AAC Accepts, published online ahead of print on 13 September 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00757-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDrug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER
Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility
More informationWhite Paper Application
White Paper Application Project Title: Whole genome sequencing of clinical strains of Mycobacterium tuberculosis Authors: David Alland, Jerrold Ellner, Susan Dorman, Moses Joloba, Clifton Barry Primary
More informationWei-Lun Huang,* Ting-Lin Chi, Mei-Hua Wu, and Ruwen Jou*
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2502 2508 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.00197-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Performance
More informationThe Efficacy of Genotype MTBDRplus Assay in Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates
The Efficacy of Genotype MTBDRplus Assay in Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates Singh Shruti S 1, Desai Pratibha B. 2 1,2 Department of
More informationDNA sequencing for the confirmation of rifampin resistance detected by Cepheid Xpert
JCM Accepted Manuscript Posted Online 4 March 2015 J. Clin. Microbiol. doi:10.1128/jcm.03433-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 DNA sequencing for the confirmation
More informationTuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka.
Bangladesh J Med Microbiol 2011; 05 (02): 06-10 Bangladesh Society of Medical Microbiologists Original Article A rapid Drug Susceptibility Test (DST) for detection of Multi-Drug Resistant (MDR) Mycobacterium
More informationImpact of the interaction of R with rifampin on the. treatment of tuberculosis studied in the mouse model ACCEPTED
AAC Accepts, published online ahead of print on 21 July 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00566-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPrevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012
Yin et al. BMC Microbiology (2016) 16:85 DOI 10.1186/s12866-016-0699-2 RESEARCH ARTICLE Open Access Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China:
More informationResearch Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System
BioMed Research International Volume 2016, Article ID 5972021, 4 pages http://dx.doi.org/10.1155/2016/5972021 Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014
TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationSaid et al. BMC Infectious Diseases 2012, 12:369
Said et al. BMC Infectious Diseases 2012, 12:369 RESEARCH ARTICLE Open Access Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant
More informationRapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa
Journal of Antimicrobial Chemotherapy Advance Access published October 21, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn433 Rapid genotypic assays to identify drug-resistant Mycobacterium
More informationCDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
More informationPatterns of rpoc Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea
ORIGINAL ARTICLE https://doi.org/10.4046/trd.2017.0042 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2018;81:222-227 Patterns of rpoc Mutations in -Resistant Mycobacterium tuberculosis Isolated
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01495.x Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katg: a decade of experience
More informationGerald Mboowa *, Carolyn Namaganda and Willy Ssengooba
Mboowa et al. BMC Infectious Diseases 2014, 14:481 RESEARCH ARTICLE Open Access Rifampicin resistance mutations in the 81 bp RRDR of rpob gene in Mycobacterium tuberculosis clinical isolates using Xpert
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment
More informationA simple, rapid and economic method for detecting multidrug-resistant tuberculosis
braz j infect dis. 2013;17(6):667 671 The Brazilian Journal of INFECTIOUS DISEASES www.elsevier.com/locate/bjid Original article A simple, rapid and economic method for detecting multidrug-resistant tuberculosis
More informationDiagnosis of TB in Belarus, statistics and challenges of establishing an accurate and timely DR-TB diagnosis in high MDR-TB prevalence settings
Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology
More informationN AB I L A I S M AI L
Evaluation of methods for generation of in vitro mutants resistant to bedaquiline, clofazimine and linezolid using Mycobacterium tuberculosis reference strains NABILA ISMAIL 1, SHAHEED V OMAR 2, NAZIR
More informationSequence analysis of fluoroquinolone resistance associated genes gyra and gyrb in clinical
JCM Accepted Manuscript Posted Online 22 June 2016 J. Clin. Microbiol. doi:10.1128/jcm.00670-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 Sequence analysis of fluoroquinolone
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationSirturo: a new treatment against multidrug resistant tuberculosis
Sirturo: a new treatment against multidrug resistant tuberculosis TB is an on-going problem WHO estimated incidence of new TB cases 2009 Global Tuberculosis Control: WHO report 2010. Available at: http://www.who.int/tb/publications/global_report/2010/en/index.html
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationMutations of rpob, katg, inha and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Isakova et al. BMC Microbiology (2018) 18:22 https://doi.org/10.1186/s12866-018-1168-x RESEARCH ARTICLE Mutations of rpob, katg, inha and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationAnalysis of mutational pattern in multidrug resistant tuberculosis (MDR TB) in a geographically isolated northeastern region of India
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-3008, p-issn:2319-7676. Volume 9, Issue 1 Ver. III (Jan. 2014), PP 04-10 Analysis of mutational pattern in multidrug resistant
More informationM.kansasii M.marinum M.avium M.simiae M.szulgai M.gordonae M.xenopi M.intermedium M.intracellulare M.scrofulaceum M.avium sp.
Molecular-genetic methods for species identification of mycobacteria Smirnova T.G., Chernousova L.N., Vorobyeva A.V., Larionova E.E., Andreevskaya S.N. Central TB Research Institute of RAMS, Moscow 2010
More informationThe current state of knowledge: genotypic vs phenotypic drug-susceptibility testing (DST)
The current state of knowledge: genotypic vs phenotypic drug-susceptibility testing (DST) Daniela M Cirillo Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute Milan Outline Concordance
More informationMolecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh
Molecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh Dr. Kaisar Ali Talukder Senior Scientist Icddr,b This presentation will
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationRapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay
Indian J Med Res 117, February 2003, pp 76-80 Rapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay Meera Sharma, Sunil Sethi, Baijayantimala
More informationOriginal Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
Int J Clin Exp Pathol 2017;10(4):4847-4851 www.ijcep.com /ISSN:1936-2625/IJCEP0045802 Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
More informationMolecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria
Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis Dr Sahajal Dhooria What is drug resistant TB? Definitions MDR TB defined as resistance to isoniazid and rifampicin, with or without resistance
More informationCDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service
CDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service Beverly Metchock, DrPH, D(ABMM) Team Lead, Reference Laboratory
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationDetection of heteroresistant Mycobacterium tuberculosis by pyrosequencing
JCM Accepts, published online ahead of print on 18 September 2013 J. Clin. Microbiol. doi:10.1128/jcm.01761-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Detection of heteroresistant
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More informationEvaluation of a Rapid Molecular Drug- Susceptibility Test for Tuberculosis
The new england journal of medicine Original Article Evaluation of a Rapid Molecular Drug- Susceptibility Test for Tuberculosis Y.L. Xie, S. Chakravorty, D.T. Armstrong, S.L. Hall, L.E. Via, T. Song, X.
More informationOnline Annexes (5-8)
2016 Online Annexes (5-8) to WHO Policy guidance: The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs 1 Contents: Annex 5: GRADE summary of findings
More informationDesigning Fluoroquinolone Breakpoints for Streptococcus pneumoniae by Using Genetics instead of Pharmacokinetics-Pharmacodynamics
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2004, p. 3630 3635 Vol. 48, No. 9 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.9.3630 3635.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationMycobacterium tuberculosis wild-type and non-wild-type MIC distributions for the novel
AAC Accepted Manuscript Posted Online 20 June 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00393-16 Copyright 2016 Yu et al. This is an open-access article distributed under the terms of the Creative
More informationOnline Annexes (5-8)
Online Annexes (5-8) to WHO Policy guidance: The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs THE END TB STRATEGY Online Annexes (5-8) to WHO
More informationMycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline
Mycobacteria Diagnostic Testing in Manitoba Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Acknowlegements: Assunta Rendina: Charge Tech HSC Lab Joyce Wolf & Dr. Meenu Sharma: NML Dr. Kanchana
More informationWhen good genes go bad
When good genes go bad Dr Kessendri Reddy NHLS Tygerberg Hospital Division of Clinical Microbiology Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine and Health Sciences Overview Cases
More informationAspirin antagonism in isonizaid treatment of tuberculosis in mice ACCEPTED. Department of Molecular Microbiology & Immunology, Bloomberg School of
AAC Accepts, published online ahead of print on 4 December 2006 Antimicrob. Agents Chemother. doi:10.1128/aac.01145-06 Copyright 2006, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPrevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China
Li et al. Antimicrobial Resistance and Infection Control (2018) 7:61 https://doi.org/10.1186/s13756-018-0348-7 RESEARCH Open Access Prevalence and patterns of drug resistance among pulmonary tuberculosis
More informationMINIREVIEW. Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy. Howard Takiff* and Elba Guerrero
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2011, p. 5421 5429 Vol. 55, No. 12 0066-4804/11/$12.00 doi:10.1128/aac.00695-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. MINIREVIEW
More informationTuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance,
Surveillance and outbreak reports Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009 D Papaventsis (dpapaventsis@yahoo.gr) 1, S Nikolaou 1, S Karabela
More informationDiagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study
Tropical Medicine and International Health doi:10.1111/tmi.12566 volume 20 no 11 pp 1431 1437 november 2015 Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment:
More informationLABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES
LABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES NDWG Annual meeting 2015, Cape Town, South Africa Rigouts Leen, Institute of Tropical Medicine, Antwerp, Belgium 1 Bedaquiline (BDQ) Sirturo
More informationFrances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS
The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationInconsistent Results with the Xpert-MTB/Rif Assay in Detection of Mycobacterium
JCM Accepts, published online ahead of print on 12 July 2013 J. Clin. Microbiol. doi:10.1128/jcm.01377-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Inconsistent Results
More informationMulti-country surveillance project on fluoroquinolones and PZA resistance
Multi-country surveillance project on fluoroquinolones and PZA resistance Matteo Zignol CPTR Rapid DST 2014 Workshop September 22-23, 2014 Washington DC, US Objectives of the FQLs and PZA surveillance
More informationkatg Mutation of Isoniazid-Resistant Isolated from Tuberculosis Patients
ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(), 3-36 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran katg Mutation of Isoniazid-Resistant Isolated from Tuberculosis Patients
More informationCharacterization of Mutations in the Rpob and Katg Gene of Mycobacterium Tuberculosis Isolates From Pasteur Institute of Tehran
2461 Int. J. Adv. Biol. Biom. Res, 2014; 2 (8), 2461-2465 IJABBR- 2014- eissn: 2322-4827 International Journal of Advanced Biological and Biomedical Research Journal homepage: www.ijabbr.com Original Article
More informationTB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai
TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%
More informationABSTRACTS. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China
182 Indian J Tuberc 2012; 59: 182-186 Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China X. Li, H.Wang, H.Jing, Y.Wang, C.Yu, J.Wang, Z. Liu, E. A. Graviss
More informationImproving Translation in TB Drug Development Through Quantitative Modeling. CPTR Workshop 2016, Washington DC
Improving Translation in TB Drug Development Through Quantitative Modeling Lessons from Recent Phase III TB Trials CPTR Workshop 2016, Washington DC Christian Lienhardt Global TB Programme WHO, Geneva,
More informationPyrosequencing Experience from Mumbai, India. Camilla Rodrigues MD Consultant Microbiologist Hinduja Hospital,Mumbai India
Pyrosequencing Experience from Mumbai, India Camilla Rodrigues MD Consultant Microbiologist Hinduja Hospital,Mumbai India Mumbai maximum city Slow Fast 1-2 D With increasing drug resistance, DST is vital
More informationMycobacterium tuberculosis and Molecular Epidemiology: An Overview
Journal of Microbiology Research 2014, 4(6A): 25-31 DOI: 10.5923/s.microbiology.201401.04 Mycobacterium tuberculosis and Molecular Epidemiology: An Overview Asho Ali Department of Biology, King Abdul Aziz
More informationTreatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
MAJOR ARTICLE Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis Karen R. Jacobson, 1 Dylan B. Tierney, 1 Christie Y. Jeon, 2 Carole D.
More informationPREVALENCE AND FACTORS ASSOCIATED WITH MULTIDRUG-RESISTANT TUBERCULOSIS AT SIRIRAJ HOSPITAL, BANGKOK, THAILAND
Multidrug-resistant Tuberculosis at Siriraj Hospital, Thailand PREVALENCE AND FACTORS ASSOCIATED WITH MULTIDRUG-RESISTANT TUBERCULOSIS AT SIRIRAJ HOSPITAL, BANGKOK, THAILAND Anupop Jitmuang 1, Parnwad
More informationRapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system
Brazilian Journal of Medical and Biological Research (2002) 35: 1127-1131 MGIT detection of multidrug-resistant M. tuberculosis ISSN 0100-879X 1127 Rapid detection of multidrug-resistant Mycobacterium
More informationEmergence and genetic characteristics of pyrazinamide resistant
1 Title page: 2 3 Emergence and genetic characteristics of pyrazinamide resistant tuberculosis in China, a multi-center study 4 5 6 Dange Li 1, Yi Hu 1,*, Jim Werngren 3, Mikael Mansjö 3, Xubin Zheng 1,
More information